FDA Approves Revolutionary Fecal Transplant Pill for Gut Infections.
TL;DR
The FDA has approved Vowst, an oral capsule containing beneficial bacteria derived from human fecal matter, to treat recurrent infections of Clostridioides difficile by balancing out the gut microbiome. Vowst was approved on the basis of two studies conducted in the U.S. and Canada, including a randomized, double-blinded placebo-controlled trial. The drug is intended to be used in conjunction with antibiotics to prevent recurrent C. difficile infections and is taken four capsules at a time daily for three days.
- FDA Approves Poop-Based Pill to Treat Hardy Gut Infections Gizmodo
- FDA approves first fecal transplant pill made from healthy bacteria found in human waste Fox News
- US approves fecal transplant pill that will obviate need for stool banks The Guardian US
- Seres to start selling 'poop pill' in June at $17,500 per course - Boston Business Journal The Business Journals
- Seres's Bacteria in a Pill Becomes First FDA-Approved Oral Microbiome Therapy MedCity News
Want the full story? Read the original reporting
Read on Gizmodo